Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension

Published:2016-01-07 Issue:4 Volume:389 Page:369-379
ISSN:0028-1298
Container-title:Naunyn-Schmiedeberg's Archives of Pharmacology
language:en
Short-container-title:Naunyn-Schmiedeberg's Arch Pharmacol

Author:

Behringer Arnica,Trappiel Manuela,Berghausen Eva Maria,ten Freyhaus Henrik,Wellnhofer Ernst,Odenthal Margarete,Blaschke Florian,Er Fikret,Gassanov Natig,Rosenkranz Stephan,Baldus Stephan,Kappert Kai,Caglayan Evren

Funder

Marga und Walter Boll Stiftung

Charité Universitätsmedizin Berlin (DE) Nachwuchskomission

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00210-015-1205-3.pdf

Reference38 articles.

1. Ameshima S, Golpon H, Cool CD, Chan D, Vandivier RW, Gardai SJ, Wick M, Nemenoff RA, Geraci MW, Voelkel NF (2003) Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth. Circ Res 92:1162–1169

2. Caglayan E, Blaschke F, Takata Y, Hsueh WA (2005) Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways. Curr Opin Pharmacol 5:135–142

3. Caglayan E, Stauber B, Collins AR, Lyon CJ, Yin F, Liu J, Rosenkranz S, Erdmann E, Peterson LE, Ross RS, Tangirala RK, Hsueh WA (2008) Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis. Diabetes 57:2470–2479

4. Crossno JT Jr, Garat CV, Reusch JE, Morris KG, Dempsey EC, McMurtry IF, Stenmark KR, Klemm DJ (2007) Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling. Am J Physiol Lung Cell Mol Physiol 292:L885–L897

5. Dias-Neto M, Luisa-Neves A, Pinho S, Goncalves N, Mendes M, Eloy C, Lopes JM, Goncalves D, Ferreira-Pinto M, Leite-Moreira AF, Henriques-Coelho T (2015) Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline. Pediatr Cardiol 36:1000–1013

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell Transcriptomic Atlas of Human Atrial Fibrillation;2024-09-11

2. Molecular mechanisms and potential therapeutic targets in the pathogenesis of hypertension in visceral adipose tissue induced by a high-fat diet;Frontiers in Cardiovascular Medicine;2024-04-16

3. The role and mechanism of AMPK in pulmonary hypertension;Therapeutic Advances in Respiratory Disease;2024-01

4. Osteopontin in Pulmonary Hypertension;Biomedicines;2023-05-07

5. Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension;Pharmacology & Therapeutics;2023-04